Lilly partners with Nvidia on AI supercomputer to speed up drug development

Core Insights - Eli Lilly is collaborating with Nvidia to develop a supercomputer aimed at enhancing drug discovery and reducing development cycles, ultimately facilitating faster access to medicines [1] Company Summary - Eli Lilly is focusing on leveraging advanced technology in partnership with Nvidia to improve the efficiency of drug development processes [1] Industry Summary - The collaboration highlights a growing trend in the pharmaceutical industry to integrate artificial intelligence and high-performance computing to accelerate drug discovery and development timelines [1]